|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 September 2001, Vol. 98, No. 6, pp. 1782-1791
HEMATOPOIESIS
Tumor necrosis factor (TNF)-mediated activation of the p55 TNF
receptor negatively regulates maintenance of cycling reconstituting
human hematopoietic stem cells
Ingunn Dybedal,
David Bryder,
Anna Fossum,
Leiv S. Rusten, and
Sten Eirik
W. Jacobsen
From the Department of Stem Cell Biology, Institute of
Laboratory Medicine, University Hospital of Lund, Lund, Sweden, and the
Department of Oncology, The Norwegian Radium Hospital, Oslo, Norway.
Hematopoietic stem cell (HSC) fate decisions between self-renewal
and commitment toward differentiation are tightly regulated in vivo.
Recent developments in HSC culture and improvements of human HSC assays
have facilitated studies of these processes in vitro. Through such
studies stimulatory cytokines critically involved in HSC maintenance in
vivo have been demonstrated to also promote HSC self-renewing divisions
in vitro. Evidence for negative regulators of HSC self-renewal is,
however, lacking. Tumor necrosis factor (TNF), if overexpressed, has
been implicated to mediate bone marrow suppression. However, whether
and how TNF might affect the function of HSC with a combined myeloid
and lymphoid reconstitution potential has not been investigated. In the
present studies in vitro conditions recently demonstrated to promote
HSC self-renewing divisions in vitro were used to study the effect of
TNF on human HSCs capable of reconstituting myelopoiesis and
lymphopoiesis in nonobese diabetic-severe combined immunodeficient
(NOD-SCID) mice. Although all cord blood and adult bone marrow
CD34+CD38 cells were capable of undergoing
cell divisions in the presence of TNF, cycling HSCs exposed to TNF in
vitro and in vivo were severely compromised in their ability to
reconstitute NOD-SCID mice and long-term cultures. The negative effect
of TNF was not dependent on the Fas pathway, and a similar effect could
be observed using a mutant TNF exclusively targeting the p55 TNF
receptor. TNF did not appear to enhance apoptosis or affect cell-cycle
distribution of cultured progenitors, but rather promoted myeloid
differentiation. Thus, TNF might regulate HSC fate by promoting their
differentiation rather than self-renewal.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. D. Milsom, B. Schiedlmeier, J. Bailey, M.-O. Kim, D. Li, M. Jansen, A. M. Ali, M. Kirby, C. Baum, L. J. Fairbairn, et al.
Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-{alpha} on Fanconi anemia hematopoietic stem and progenitor cells
Blood,
May 21, 2009;
113(21):
5111 - 5120.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Briot, G. Mace-Aime, F. Subra, and F. Rosselli
Aberrant activation of stress-response pathways leads to TNF-{alpha} oversecretion in Fanconi anemia
Blood,
February 15, 2008;
111(4):
1913 - 1923.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Schiedlmeier, A. C. Santos, A. Ribeiro, N. Moncaut, D. Lesinski, H. Auer, K. Kornacker, W. Ostertag, C. Baum, M. Mallo, et al.
HOXB4's road map to stem cell expansion
PNAS,
October 23, 2007;
104(43):
16952 - 16957.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Sejas, R. Rani, Y. Qiu, X. Zhang, S. R. Fagerlie, H. Nakano, D. A. Williams, and Q. Pang
Inflammatory Reactive Oxygen Species-Mediated Hemopoietic Suppression in Fancc-Deficient Mice
J. Immunol.,
April 15, 2007;
178(8):
5277 - 5287.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. Iosif, C. T. Ekdahl, H. Ahlenius, C. J. H. Pronk, S. Bonde, Z. Kokaia, S.-E. W. Jacobsen, and O. Lindvall
Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis.
J. Neurosci.,
September 20, 2006;
26(38):
9703 - 9712.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Bijangi-Vishehsaraei, M. R. Saadatzadeh, A. Werne, K. A. W. McKenzie, R. Kapur, H. Ichijo, and L. S. Haneline
Enhanced TNF-{alpha}-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1
Blood,
December 15, 2005;
106(13):
4124 - 4130.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Beyne-Rauzy, N. Prade-Houdellier, C. Demur, C. Recher, J. Ayel, G. Laurent, and V. Mansat-De Mas
Tumor necrosis factor-{alpha} inhibits hTERT gene expression in human myeloid normal and leukemic cells
Blood,
November 1, 2005;
106(9):
3200 - 3205.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Isgro, M. Marziali, I. Mezzaroma, G. Luzi, A. M. Mazzone, V. Guazzi, G. Andolfi, B. Cassani, A. Aiuti, and F. Aiuti
Bone Marrow Clonogenic Capability, Cytokine Production, and Thymic Output in Patients with Common Variable Immunodeficiency
J. Immunol.,
April 15, 2005;
174(8):
5074 - 5081.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Hanash and R. B. Levy
Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation
Blood,
February 15, 2005;
105(4):
1828 - 1836.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Yang, I. Dybedal, D. Bryder, L. Nilsson, E. Sitnicka, Y. Sasaki, and S. E. W. Jacobsen
IFN-{gamma} Negatively Modulates Self-Renewal of Repopulating Human Hemopoietic Stem Cells
J. Immunol.,
January 15, 2005;
174(2):
752 - 757.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Nakamura, T. Kouro, P. W. Kincade, A. Malykhin, K. Maeda, and K. M. Coggeshall
Src Homology 2-containing 5-Inositol Phosphatase (SHIP) Suppresses an Early Stage of Lymphoid Cell Development through Elevated Interleukin-6 Production by Myeloid Cells in Bone Marrow
J. Exp. Med.,
January 20, 2004;
199(2):
243 - 254.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Park, P. T. Vuong, S. de Vos, D. Douer, and H. P. Koeffler
Comparative analysis of genes regulated by PML/RAR{alpha} and PLZF/RAR{alpha} in response to retinoic acid using oligonucleotide arrays
Blood,
November 15, 2003;
102(10):
3727 - 3736.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Li, P. A. Plett, Y. Yang, P. Hong, B. Freie, E. F. Srour, C. M. Orschell, D. W. Clapp, and L. S. Haneline
Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control
Blood,
September 15, 2003;
102(6):
2081 - 2084.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Sitnicka, N. Buza-Vidas, S. Larsson, J. M. Nygren, K. Liuba, and S. E. W. Jacobsen
Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells
Blood,
August 1, 2003;
102(3):
881 - 886.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Dybedal, L. Yang, D. Bryder, I. Aastrand-Grundstrom, K. Leandersson, and S. E. W. Jacobsen
Human reconstituting hematopoietic stem cells up-regulate Fas expression upon active cell cycling but remain resistant to Fas-induced suppression
Blood,
July 1, 2003;
102(1):
118 - 126.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-C. Gu, J. Kortesmaa, K. Tryggvason, J. Persson, P. Ekblom, S.-E. Jacobsen, and M. Ekblom
Laminin isoform-specific promotion of adhesion and migration of human bone marrow progenitor cells
Blood,
February 1, 2003;
101(3):
877 - 885.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Nilsson, I. Astrand-Grundstrom, K. Anderson, I. Arvidsson, P. Hokland, D. Bryder, L. Kjeldsen, B. Johansson, E. Hellstrom-Lindberg, R. Hast, et al.
Involvement and functional impairment of the CD34+CD38-Thy-1+ hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8
Blood,
June 17, 2002;
100(1):
259 - 267.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
